(Total Views: 857)
Posted On: 09/30/2020 2:39:37 PM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
From an earlier post of mine.
If the 10% (13 patients) is even a bit close there is no way we don't seek approval on interim.
Quote:
I think worst case scenario there's a 25% mortality rate in SOC and a 10% mortality rate for leronlimab.
The 25% worst case scenario was based on the Dexamethasone's 25% mortality in non-invasive oxygen.
If the 10% (13 patients) is even a bit close there is no way we don't seek approval on interim.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)